Sort by
Refine Your Search
-
qualities are in line with the faculty and university research policies . What we offer A doctoral scholarship for a period of 1 year. Following a positive evaluation, the scholarship can be renewed
-
period of 1 year. Following a positive evaluation, the scholarship can be renewed for another 3 years (total 4 years). Participation in an exciting European project at the interface of catalysis, materials
-
margins in breast cancer surgery, based on a novel Raman spectroscopic technology (IOARM-Raman) that will fit in the surgical work flow. To determine the potential improvement of resection margin status in
-
output on time. What we offer We offer a doctoral scholarship for a period of one year. Following a positive evaluation, the scholarship can be renewed for another three years. The planned start date is 1
-
but not required: Experience with clinical trials Experience with data analysis Experience with RedCAP What we offer We offer a doctoral scholarship for a period of one year. Following a positive
-
with the faculty and university research policies . You act with attention to quality, integrity, creativity and cooperation. What we offer We offer a doctoral scholarship for a period of two years
-
omics. Colorectal cancer (CRC) is the third most common malignancy and is the second leading cause of cancer-related deaths worldwide. Current treatment options such as chemotherapy and targeted
-
malignancy and is the second leading cause of cancer-related deaths worldwide. Current treatment options such as chemotherapy and targeted/immunotherapies are insufficient due to resistance development and
-
handling, molecular biology techniques, data handling, statistical analyses and science communication. We offer a doctoral scholarship for a period of one year. Following a positive evaluation, the
-
scholarship for a period of two years. Following a positive evaluation, the scholarship can be renewed for another two years. The planned start date is 1st of September 2025 or as soon as possible after